Related Experiment Video
Updated: Sep 10, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Impact of a Checklist-Based Strategy for Cardiac Amyloidosis Screening on Diagnosis Rates in Heart Failure Patients
Alberto Pérez-Nieva1, Pau Llàcer1, Prado Salamanca-Bautista2
1Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain; Department of Medicine and Medical Specialties, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Insights
Implementing a checklist for transthyretin-associated cardiac amyloidosis (ATTR-CM) in heart failure (HF) units increased diagnosis rates tenfold. A low QRS-to-mass ratio was the strongest predictor of ATTR-CM in elderly patients.
Area of Science:
- Cardiology
- Medical Diagnostics
- Public Health
Background:
- Transthyretin-associated cardiac amyloidosis (ATTR-CM) is an underdiagnosed cause of heart failure (HF), especially in older adults.
- Delayed diagnosis of ATTR-CM hinders access to effective disease-modifying treatments.
- Early detection is crucial for improving patient outcomes in ATTR-CM.
Purpose of the Study:
- To assess the impact of a checklist-based screening strategy for ATTR-CM in specialized heart failure (HF) units.
- To evaluate the feasibility and effectiveness of implementing a structured diagnostic workup for ATTR-CM.
- To identify key predictors of ATTR-CM in elderly HF patients.
Main Methods:
- A prospective, multicenter, observational study involving elderly patients (≥65 years) with HF and positive screening checklists.
- Comparison with a retrospective control cohort from the same centers to determine ATTR-CM diagnosis rates.
- Structured diagnostic workup for ATTR-CM, including identification of independent predictors and 6-month clinical outcomes.
Main Results:
- The prospective cohort showed a significantly higher ATTR-CM diagnosis rate (21.6%) compared to the retrospective cohort (1.8%).
- A low QRS-to-mass ratio was the strongest independent predictor of ATTR-CM (OR 41.02), followed by septal thickness, age, LV mass index, and BMI.
- Clinical outcomes at 6 months were comparable between patients with and without ATTR-CM.
Conclusions:
- A checklist-based screening strategy effectively increased ATTR-CM detection tenfold in elderly HF patients.
- Low QRS-to-mass ratio is a key indicator for ATTR-CM, aiding early diagnosis.
- Checklist implementation is a feasible approach to improve the early identification of underrecognized ATTR-CM.
Background:
Transthyretin-associated cardiac amyloidosis (ATTR-CM) is an underdiagnosed cause of heart failure (HF), particularly in elderly patients. Delayed diagnosis limits access to emerging disease-modifying therapies. We aimed to evaluate the impact of implementing a checklist-based screening strategy for ATTR-CM in specialized HF units.
Methods:
We conducted a prospective, multicenter, observational study in three Spanish tertiary hospitals, enrolling patients ≥65 years old with HF and a positive checklist based on ESC red-flag criteria. All underwent a structured diagnostic workup for ATTR-CM. A retrospective control cohort from the same centers was used for comparison. The primary outcome was ATTR-CM diagnosis rate. Secondary analyses included identification of independent predictors of ATTR-CM and clinical outcomes at 6 months.
Results:
Of 102 patients in the prospective cohort, 22 (21.6 %) were diagnosed with ATTR-CM, compared to only 2 of 110 patients (1.8 %) in the retrospective cohort (p < 0.001). The strongest independent predictor of ATTR-CM was a low QRS-to-mass ratio (OR 41.02; 95 % CI: 1.92-875.25; p = 0.017), followed by increased septal thickness, older age, higher left ventricular mass index, and lower body mass index. At 6-month follow-up, clinical outcomes were similar between patients with and without ATTR-CM.
Conclusions:
In this prospective multicenter study of elderly HF patients, implementing a diagnostic checklist increased ATTR-CM detection tenfold compared to historical controls. A low QRS-to-mass ratio emerged as the strongest independent predictor. Checklist-based screening is a feasible strategy to improve early diagnosis of this underrecognized condition.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiac Catheterization I: Pre-Procedure Overview
Heart Failure IV: Classification and Diagnostic Evaluation
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy V: Interprofessional Care
Dysrhythmias V: Evaluating Dysrhythmias

